Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by jopatcloon Sep 10, 2024 8:37am
58 Views
Post# 36216277

RE:Intracardiac Echocardiography (ICE) Market Worth $545Million

RE:Intracardiac Echocardiography (ICE) Market Worth $545Million With FDA V4.0 approved will be among the biggest in healthcare.( Other Companies that are Operating in this Market Globally: Interesting Ventripoint ) Fortune Health Study 5 days ago Intracardiac Echocardiography (ICE) Market Worth $545 Million Download a PDF Brochure: https://lnkd.in/dGcUFgPK Intracardiac Echocardiography (ICE) Market by Product (Ultrasound (2D, 3D/4D, Doppler), Catheter, Console, Software), Application (Valve Defects, Electrophysiology, Monitoring), Enduser (Hospital, ASC, Diagnostic Centers) & Region Global Forecasts to 2029 : GE Healthcare (US), Medtronic (Ireland), Johnson & Johnson Medtech (US), Siemens Healthineers (Germany), Abbott Laboratories (US) and Boston Scientific Corporation (US)
<< Previous
Bullboard Posts
Next >>